Free Trial
NYSE:HIMS

Hims & Hers Health (HIMS) Stock Price, News & Analysis

Hims & Hers Health logo
$32.69 -2.35 (-6.72%)
As of 11:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Hims & Hers Health Stock (NYSE:HIMS)

Key Stats

Today's Range
$31.75
$33.89
50-Day Range
$25.41
$51.37
52-Week Range
$11.20
$72.98
Volume
22.01 million shs
Average Volume
16.34 million shs
Market Capitalization
$7.28 billion
P/E Ratio
74.50
Dividend Yield
N/A
Price Target
$36.92
Consensus Rating
Hold

Company Overview

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

HIMS MarketRank™: 

Hims & Hers Health scored higher than 64% of companies evaluated by MarketBeat, and ranked 240th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on 3 buy ratings, 8 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    Hims & Hers Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hims & Hers Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hims & Hers Health are expected to grow by 79.31% in the coming year, from $0.29 to $0.52 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hims & Hers Health is 73.61, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.64.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hims & Hers Health is 73.61, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.34.

  • Price to Book Value per Share Ratio

    Hims & Hers Health has a P/B Ratio of 20.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Hims & Hers Health's valuation and earnings.
  • Percentage of Shares Shorted

    33.32% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 5.00%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Hims & Hers Health does not currently pay a dividend.

  • Dividend Growth

    Hims & Hers Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    33.32% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently increased by 5.00%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Hims & Hers Health has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 35 news articles for Hims & Hers Health this week, compared to 21 articles on an average week.
  • Search Interest

    115 people have searched for HIMS on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.
  • MarketBeat Follows

    36 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 44% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $27,992,450.00 in company stock.

  • Percentage Held by Insiders

    17.71% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Hims & Hers Health's insider trading history.
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Stock News Headlines

Konskie, Poland - March 27, 2025: Hims and Hers Health company logo displayed on mobile phone — Stock Editorial Photography
Hims & Hers Stock Soars on Novo Nordisk Collaboration
Hims & Hers stock rallies by over 25% on news of a collaboration with Novo Nordisk and its weight loss flagship products, and that's not all.
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Hims & Hers Health: GLP-1 Deals De-Risk The Story
See More Headlines

HIMS Stock Analysis - Frequently Asked Questions

Hims & Hers Health's stock was trading at $24.18 at the beginning of 2025. Since then, HIMS shares have increased by 33.2% and is now trading at $32.2150.
View the best growth stocks for 2025 here
.

Hims & Hers Health, Inc. (NYSE:HIMS) posted its quarterly earnings results on Monday, February, 24th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. The firm earned $481.14 million during the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a trailing twelve-month return on equity of 10.97%.
Read the conference call transcript
.

Top institutional investors of Hims & Hers Health include Yong Rong HK Asset Management Ltd (1.08%), Bank of New York Mellon Corp (0.57%), IMC Chicago LLC and Principal Financial Group Inc. (0.36%). Insiders that own company stock include Melissa Baird, David B Wells, Alex Bard, Patrick Harrison Carroll, Michael Chi, Soleil Boughton, Jules A Maltz, Oluyemi Okupe, Christopher D Payne, Andrew Dudum, Christiane Pendarvis, Irene Becklund, Irene Becklund, Anja Manuel and Lynne Chou O'keefe.
View institutional ownership trends
.

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
2/24/2025
Today
4/29/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NYSE:HIMS
Fax
N/A
Employees
650
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$36.92
High Stock Price Target
$68.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+5.2%
Consensus Rating
Hold
Rating Score (0-4)
2.08
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
79.73
Forward P/E Ratio
120.97
P/E Growth
N/A
Net Income
$-23,550,000.00
Pretax Margin
4.16%

Debt

Sales & Book Value

Annual Sales
$1.48 billion
Price / Cash Flow
N/A
Book Value
$1.61 per share
Price / Book
21.79

Miscellaneous

Free Float
179,786,000
Market Cap
$7.79 billion
Optionable
Optionable
Beta
1.65
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:HIMS) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners